Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Farmers Insurance
Teva
US Army
Citi
Cipla
Fish and Richardson
US Department of Justice

Generated: July 23, 2018

DrugPatentWatch Database Preview

ALFUZOSIN HYDROCHLORIDE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for alfuzosin hydrochloride and what is the scope of alfuzosin hydrochloride patent protection?

Alfuzosin hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Mylan, Sun Pharma Global, Teva Pharms, Torrent Pharms, Unichem Labs Ltd, Wockhardt Ltd, and Concordia Pharms Inc, and is included in ten NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Alfuzosin hydrochloride has fifty-three patent family members in thirty-eight countries.

There are nineteen drug master file entries for alfuzosin hydrochloride. Nineteen suppliers are listed for this compound.
Pharmacology for ALFUZOSIN HYDROCHLORIDE
Synonyms for ALFUZOSIN HYDROCHLORIDE
(+-)-N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furamide monohydrochloride
133880-44-1
2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)-
4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline Hydrochloride
403A681
81403-68-1
81403-80-7 (Parent)
AB0008072
AB2000094
AC-1116
AC1L2GRP
AC1Q5PED
AKOS015966770
Alfetim
Alfoten
Alfuzosin (hydrochloride)
Alfuzosin for peak identification, European Pharmacopoeia (EP) Reference Standard
Alfuzosin for system suitability A, European Pharmacopoeia (EP) Reference Standard
Alfuzosin for system suitability, European Pharmacopoeia (EP) Reference Standard
Alfuzosin HCl
Alfuzosin hydrochloride (JAN/USAN)
Alfuzosin hydrochloride (Uroxatral)
Alfuzosin hydrochloride [USAN:USP]
Alfuzosin hydrochloride [USAN]
Alfuzosin hydrochloride, >=98% (HPLC), solid
Alfuzosin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Alfuzosin hydrochloride, pharmaceutical secondary standard; traceable to USP and PhEur
Alfuzosin hydrochloride, United States Pharmacopeia (USP) Reference Standard
Alfuzosin hydrochloride;
API0001407
AS-14240
AT-12271
BC677639
BCP9000271
BCPP000417
C19H27N5O4
C19H28ClN5O4
CAS-81403-68-1
CC-23835
CCG-213373
CHEBI:32286
CHEMBL1723
CS-2087
CTK8F7637
D01692
D0H1YQ
DSSTox_CID_25514
DSSTox_GSID_45514
DSSTox_RID_80924
DTXSID3045514
FT-0630890
HMS1569A05
HY-B0192A
K448
KS-00000XK8
LP00224
LS-70107
MFCD00879135
MolPort-006-391-851
N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide hydrochloride
N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide Hydrochloride
n-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide hydrochloride
N-[3-[4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
n-{3-[(4-amino-6,7-dimethoxychinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamidhydrochlorid
NCGC00016946-01
NCGC00095152-09
NCGC00260909-01
s1409
SCHEMBL179910
SL 77 499-10
SL 77499-10
SL-77.0499-10
SL-77499
SL-77499-10
SL-7749910
Tox21_110701
Tox21_110701_1
Tox21_500224
Urion
Uroxatral
Uroxatral (TN)
Uroxatral hydrochloride
Uroxatral, Alfuzosin hydrochloride
Xatral
Xatral OD
Xatral Retard
Xatral SR
Xatral XL
YTNKWDJILNVLGX-UHFFFAOYSA-N

US Patents and Regulatory Information for ALFUZOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079054-001 Jul 18, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079057-001 Jul 18, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079014-001 Jul 18, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079060-001 Aug 30, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for ALFUZOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287-001 Jun 12, 2003 ➤ Sign Up ➤ Sign Up
Concordia Pharms Inc UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287-001 Jun 12, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Accenture
Fish and Richardson
Citi
Argus Health
McKesson
Queensland Health
Moodys
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.